Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Comparison of transdermal electromotive administration of verapamil and dexamethasone versus intra-lesional injection for Peyronie's disease.

Mehrsai AR, Namdari F, Salavati A, Dehghani S, Allameh F, Pourmand G.

Andrology. 2013 Jan;1(1):129-32. doi: 10.1111/j.2047-2927.2012.00018.x. Epub 2012 Oct 23.

2.

A prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease.

Di Stasi SM, Giannantoni A, Stephen RL, Capelli G, Giurioli A, Jannini EA, Vespasiani G.

J Urol. 2004 Apr;171(4):1605-8.

PMID:
15017231
3.

Transdermal electromotive administration of verapamil and dexamethasone for Peyronie's disease.

Di Stasi SM, Giannantoni A, Capelli G, Jannini EA, Virgili G, Storti L, Vespasiani G.

BJU Int. 2003 Jun;91(9):825-9.

4.
5.

Transdermal electromotive multi-drug administration for Peyronie's disease: preliminary results.

Montorsi F, Salonia A, Guazzoni G, Barbieri L, Colombo R, Brausi M, Scattoni V, Rigatti P, Pizzini G.

J Androl. 2000 Jan-Feb;21(1):85-90.

6.
7.

The effectiveness of transdermal electromotive administration with verapamil and dexamethasone in the treatment of Peyronie's disease.

Tuygun C, Ozok UH, Gucuk A, Bozkurt IH, Imamoglu MA.

Int Urol Nephrol. 2009;41(1):113-8. doi: 10.1007/s11255-008-9408-x. Epub 2008 Jul 1.

PMID:
18592390
8.

Transdermal iontophoresis with verapamil and dexamethasone in the acute phase of peyronie's disease. Our experience.

Garrido Abad P, Coloma A, Herranz LM, Jiménez M, Suárez C, Prieto MD, Formoso T, Fernández Arjona M.

Arch Esp Urol. 2012 Oct;65(8):745-51. English, Spanish.

PMID:
23117682
10.

Iontophoresis for treatment of Peyronie's disease.

Riedl CR, Plas E, Engelhardt P, Daha K, Pflüger H.

J Urol. 2000 Jan;163(1):95-9.

PMID:
10604323
11.

[Transdermal iontophoresis with dexamethasone and verapamil for Peyronie's disease].

Cabello Benavente R, Moncada Iribarren I, de Palacio España A, Hernández Villaverde A, Monzó JI, Hernández Fernández C.

Actas Urol Esp. 2005 Nov-Dec;29(10):955-60. Spanish.

PMID:
16447593
12.

Oral propionyl-l-carnitine and intraplaque verapamil in the therapy of advanced and resistant Peyronie's disease.

Cavallini G, Biagiotti G, Koverech A, Vitali G.

BJU Int. 2002 Jun;89(9):895-900.

13.

Efficacy of vitamin E in the conservative treatment of Peyronie's disease: legend or reality? A controlled study of 70 cases.

Paulis G, Brancato T, D'Ascenzo R, De Giorgio G, Nupieri P, Orsolini G, Alvaro R.

Andrology. 2013 Jan;1(1):120-8. doi: 10.1111/j.2047-2927.2012.00007.x. Epub 2012 Sep 7.

14.

Intralesional verapamil for the treatment of Peyronie's disease: a review.

Levine LA, Estrada CR.

Int J Impot Res. 2002 Oct;14(5):324-8. Review.

15.

Intralesional verapamil prevents the progression of Peyronie's disease.

Bennett NE, Guhring P, Mulhall JP.

Urology. 2007 Jun;69(6):1181-4.

PMID:
17572211
16.

A prospective, randomized, single - blind study comparing intraplaque injection of thiocolchicine and verapamil in Peyronie's Disease: a pilot study.

Toscano L Jr, Rezende MV, Mello LF, Paulillo D, Glina S.

Int Braz J Urol. 2016 Sep-Oct;42(5):1005-1009. doi: 10.1590/S1677-5538.IBJU.2015.0598.

17.

Tunica albuginea tissue analysis after electromotive drug administration.

Levine LA, Estrada CR, Shou W, Cole A.

J Urol. 2003 May;169(5):1775-8.

PMID:
12686831
18.

Peironimev-Plus® in the treatment of chronic inflammation of tunica albuginea (Peyronie's disease). results of a controlled study.

Paulis G, Cavallini G, Brancato T, Alvaro R.

Inflamm Allergy Drug Targets. 2013 Feb;12(1):61-7.

PMID:
23004005
19.

Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study.

Shirazi M, Haghpanah AR, Badiee M, Afrasiabi MA, Haghpanah S.

Int Urol Nephrol. 2009;41(3):467-71. doi: 10.1007/s11255-009-9522-4. Epub 2009 Feb 6.

PMID:
19199072
20.

[Clinical effects of verapamil in the treatment of Peyronie's disease].

Arena F, Peracchia G, Di Stefano C, Passari A, Larosa M, Cortellini P.

Acta Biomed Ateneo Parmense. 1995;66(6):269-72. Italian.

PMID:
8928594

Supplemental Content

Support Center